ANG and deep vein thrombosis: Secondary outcomes: ICU free days, hospital length of stay, time to wean from mechanical ventilation, PaO2/FiO2 changes during administration of drug, incidence of deep vein thrombosis, changes in inflammatory markers, plasma levels of ANG‐II and ANG‐(1‐7), CT scan changes